XML 13 R2.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Income Statement [Abstract]        
Net sales $ 483,400 $ 463,567 $ 926,314 $ 933,326
Cost of goods sold (excluding amortization expense - See Note 13) 311,677 287,849 593,331 576,045
Gross profit 171,723 175,718 332,983 357,281
Selling, general and administrative expenses 126,600 116,949 245,646 241,129
Impairment charges 88,840 0 88,840 0
Restructuring and related charges, net 8,793 320 23,383 2,177
Operating (loss) income (52,510) 58,449 (24,886) 113,975
Other (expense) income, net (653) 422 (1,362) 1,502
Interest expense (12,779) (10,754) (22,324) (21,578)
(Loss) income before taxes and equity in net income of associated companies (65,942) 48,117 (48,572) 93,899
Taxes on income before equity in net income of associated companies 5,472 15,778 13,014 28,286
(Loss) income before equity in net income of associated companies (71,414) 32,339 (61,586) 65,613
Equity in net income of associated companies 4,851 2,571 7,940 4,555
Net (loss) income (66,563) 34,910 (53,646) 70,168
Less: Net income attributable to noncontrolling interest 17 25 12 56
Net (loss) income attributable to Quaker Chemical Corporation $ (66,580) $ 34,885 $ (53,658) $ 70,112
Per share data:        
Net income attributable to Quaker Chemical Corporation common shareholders – basic (in dollars per share) $ (3.78) $ 1.94 $ (3.04) $ 3.90
Net income attributable to Quaker Chemical Corporation common shareholders – diluted (in dollars per share) (3.78) 1.94 (3.04) 3.89
Dividends declared (in dollars per share) $ 0.485 $ 0.455 $ 0.970 $ 0.910